Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer

Oncogene

Volumn 13, Issue 9, 1996, Pages 1893-1899

  Ou, Xiaolan ^a   Campau, Steve ^a   Slusher, Rodney ^a   Jasti, Rajani K ^b   Mabry, Mack ^b   Kalemkerian, Gregory P ^a,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Lung cancer; myc; Retinoic acid; Transcription

Indexed keywords

MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE INDUCTION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; ONCOGENE MYC; PRIORITY JOURNAL; RNA DEGRADATION; TRANSCRIPTION REGULATION;

CARCINOMA, SMALL CELL; CELL DIVISION; CYCLOHEXIMIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0029857637     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bentley DL and Groudine M. (1986). Nature, 321, 702-706.
2. Bernard O, Drago J and Sheng H. (1992). Neuron, 9, 1217-1224.
3. Brennan J, O'Connor T, Makuch RW, Simmons AM, Russell E, Linnoila RI, Phelps RM, Gazdar AF, Ihde DC and Johnson BE. (1991). Cancer Res., 51, 1708-1712.
4. Birrer MJ, Segal S, DeGreve JS, Kaye F, Sausville EA and Minna JD. (1988). Mol. Cell. Biol., 8, 2668-2673.
5. Brooks BJ, Battey J, Nau MM, Gazdar AF and Minna JD. (1987). Adv. Viral Oncol., 7, 155-172.
6. Celano P, Berchtold C and Casero RA. (1989). BioTechniques, 7, 942-944.
7. DePinho RA, Schreiber-Agus N and Alt FW. (1991). Adv. Cancer Res., 57, 1-46.
8. Dony C, Kessel M and Gruss P. (1985). Nature, 317, 636-639.
9. Doyle LA, Giangiulo D, Hussain H, Park H-J, Yen R-WC and Borges M. (1989). Cancer Res., 49, 6745-6751.
10. Gazzeri S, Brambilla E, Jacrot M, Chauvin C, Benabid AL and Brambilla C. (1991). Cancer Res., 51, 2566-2579.
11. Gebert JF, Moghal N, Frangioni JV, Sugarbaker DJ and Neel BG. (1991). Oncogene, 6, 1859-1868.
12. Geradts J, Chen J-Y, Russell EK, Yankaskas JR, Nieves L and Minna JD. (1993). Cell Growth & Differ., 4, 799-809.
13. Gudas LJ, Sporn MB and Roberts AB. (1994). The Retinoids, Sporn MB, Roberts AB and Goodman DS (eds). Raven Press: New York, pp. 443-520.
14. Hong WK and Lotan R (eds). (1993). Retinoids in Oncology. Marcel Dekker: New York.
15. Houle B, Rochette-Egly C and Bradley WEC. (1993). Proc. Natl. Acad. Sci. USA, 90, 985-989.
16. Ingvarsson S, Sundaresan S, Jin P, Franke U, Asker C, Sumegi J, Klein G and Sejersen T. (1988). Oncogene, 3, 679-685.
17. Jetten A, Nervi C and Vollberg TM. (1992). J. Natl. Cancer Inst. Monogr., 13, 93-100.
18. Johnson BE. (1996). Lung Cancer: Principles and Practice. Pass HI, Mitchell JB, Johnson DH and Turrisi AT (eds). Lippincott-Raven Publishers: Philadelphia, pp. 83-98.
19. Kalemkerian G, Jasti R, Celano P, Casero R and Mabry M. (1992). Proc. Am. Assoc. Cancer Res., 33, 370.
20. Kalemkerian GP, Jasti RK, Celano P, Nelkin BD and Mabry M. (1994). Cell Growth & Differ., 5, 55-60.
21. Kaye F, Battey J, Nau M, Brooks B, Seifter E, DeGreve J, Birrer M, Sausville E and Minna J. (1988). Mol. Cell. Biol., 8, 186-195.
22. Kim Y-H, Dohi DF, Han GR, Zou C-P, Oridate N, Walsh GL, Nesbitt JC, Xu X-C, Hong WK, Lotan R and Kurie JM. (1995). Cancer Res., 55, 5603-5610.
23. Krumm A, Meulia T and Groudine M. (1993). BioEssays, 15, 659-665.
24. Krupitza G, Hulla W, Harant H, Dittrich E, Kallay E, Huber H, Grunt T and Dittrich C. (1995). Int. J. Cancer, 61, 649-657.
25. Krystal G, Birrer M, Way J, Nau M, Sausville E, Thompson C, Minna J and Battey J. (1988). Mol. Cell. Biol., 8, 3373-3381.
26. Leid M, Kastner P and Chambon P. (1992). Trends Biol. Sci., 17, 427-433.
27. Lippman SM, Kessler JF and Meyskens FL. (1987). Cancer Treat. Rep., 71, 493-515.
28. Miller WH, Moy D, Li A, Grippo JF and Dmitrovsky E. (1990). Oncogene, 5, 511-517.
29. Moroy T, Verbeek S, Ma A, Achacosa P, Berns A and Alt F. (1991). Oncogene, 6, 1941-1947.
30. Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF and Minna JD. (1985). Nature, 318, 69-73.
31. Prins J, DeVries EGE and Mulder NH. (1993). Anticancer Res., 13, 1373-1386.
32. Rygaard K, Vindelov LL and Spang-Thomsen M. (1993). Int. J. Cancer, 54, 144-152.
33. Saksela K. (1990). J. Cell. Biochem., 42, 153-180.
34. Smith MA, Parkinson DR, Cheson BD and Friedman MA. (1992). J. Clin. Oncol., 10, 839-864.
35. Sporn MB and Roberts AB. (1984). J. Natl. Cancer Inst., 73, 1381-1386.
36. Takahashi T, Obata Y, Sekido Y, Hida T, Ueda R, Watanabe H, Ariyoshi Y, Sugiura T and Takahashi T. (1989). Cancer Res., 49, 2683-2688.
37. Thiele C, Deutsch LA and Israel MA. (1988). Oncogene, 3, 281-288.
38. Wada RK, Seeger RC, Reynolds CP, Alloggiamento T, Yamashiro JM, Ruland C, Black AC and Rosenblatt JD. (1992). Oncogene, 7, 711-717.
39. Weber E, Jasti RK, Nelkin BD, Neel BG, Dillehay L, Williams J and Mabry M. (1996). Proc. Am. Assoc. Cancer Res., 37, 503.
40. Westin EH, Wong-Staal F, Gelmann EP, Favera RD, Papas TS, Lautenberger JA, Eva A, Reddy P, Tronick SR, Aaronson SA and Gallo RC. (1982). Proc. Natl. Acad. Sci. USA, 79, 2490-2494.
41. Xu L, Morgenbesser SD and DePinho RA. (1991). Mol. Cell. Biol., 11, 6007-6015.